274 related articles for article (PubMed ID: 20631091)
1. Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity.
Hoffmann M; Wu YJ; Gerber M; Berger-Rentsch M; Heimrich B; Schwemmle M; Zimmer G
J Gen Virol; 2010 Nov; 91(Pt 11):2782-93. PubMed ID: 20631091
[TBL] [Abstract][Full Text] [Related]
2. Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression.
Kim GN; Kang CY
Virology; 2007 Jan; 357(1):41-53. PubMed ID: 16962155
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
Fredericksen BL; Whitt MA
Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
[TBL] [Abstract][Full Text] [Related]
4. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis.
Ahmed M; McKenzie MO; Puckett S; Hojnacki M; Poliquin L; Lyles DS
J Virol; 2003 Apr; 77(8):4646-57. PubMed ID: 12663771
[TBL] [Abstract][Full Text] [Related]
5. Mutations at two conserved acidic amino acids in the glycoprotein of vesicular stomatitis virus affect pH-dependent conformational changes and reduce the pH threshold for membrane fusion.
Fredericksen BL; Whitt MA
Virology; 1996 Mar; 217(1):49-57. PubMed ID: 8599235
[TBL] [Abstract][Full Text] [Related]
6. Identification of a consensus mutation in M protein of vesicular stomatitis virus from persistently infected cells that affects inhibition of host-directed gene expression.
Ahmed M; Lyles DS
Virology; 1997 Oct; 237(2):378-88. PubMed ID: 9356348
[TBL] [Abstract][Full Text] [Related]
7. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions.
Johnson JE; Rodgers W; Rose JK
Virology; 1998 Nov; 251(2):244-52. PubMed ID: 9837788
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cholesterol-free insect cells infectible by baculoviruses: effects of cholesterol on VSV fusion and infectivity and on cytotoxicity induced by influenza M2 protein.
Cleverley DZ; Geller HM; Lenard J
Exp Cell Res; 1997 Jun; 233(2):288-96. PubMed ID: 9194491
[TBL] [Abstract][Full Text] [Related]
9. Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function.
Lyles DS; McKenzie MO
Virology; 1997 Mar; 229(1):77-89. PubMed ID: 9123880
[TBL] [Abstract][Full Text] [Related]
10. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion.
Kahn JS; Schnell MJ; Buonocore L; Rose JK
Virology; 1999 Feb; 254(1):81-91. PubMed ID: 9927576
[TBL] [Abstract][Full Text] [Related]
11. Expression of additional genes in a vector derived from a minimal RNA virus.
Rolls MM; Haglund K; Rose JK
Virology; 1996 Apr; 218(2):406-11. PubMed ID: 8610469
[TBL] [Abstract][Full Text] [Related]
12. Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors.
Kim GN; Wu K; Hong JP; Awamleh Z; Kang CY
J Virol; 2015 Jun; 89(12):6338-51. PubMed ID: 25855732
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy.
Janelle V; Brassard F; Lapierre P; Lamarre A; Poliquin L
J Virol; 2011 Jul; 85(13):6513-20. PubMed ID: 21561919
[TBL] [Abstract][Full Text] [Related]
14. Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression.
Lyles DS; McKenzie MO; Ahmed M; Woolwine SC
Virology; 1996 Nov; 225(1):172-80. PubMed ID: 8918544
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
Ahmed M; Cramer SD; Lyles DS
Virology; 2004 Dec; 330(1):34-49. PubMed ID: 15527832
[TBL] [Abstract][Full Text] [Related]
16. Basic amino acid residues at the carboxy-terminal eleven amino acid region of the phosphoprotein (P) are required for transcription but not for replication of vesicular stomatitis virus genome RNA.
Das T; Pattnaik AK; Takacs AM; Li T; Hwang LN; Banerjee AK
Virology; 1997 Nov; 238(1):103-14. PubMed ID: 9375014
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of interferon action. Interferon alpha inhibits vesicular stomatitis virus primary transcript accumulation in P1/eIF-2 alpha protein kinase-deficient human fibroblast cells.
Zhang XT; Samuel CE
J Biol Regul Homeost Agents; 1987; 1(4):157-65. PubMed ID: 2845723
[TBL] [Abstract][Full Text] [Related]
18. Assembly functions of vesicular stomatitis virus matrix protein are not disrupted by mutations at major sites of phosphorylation.
Kaptur PE; McKenzie MO; Wertz GW; Lyles DS
Virology; 1995 Feb; 206(2):894-903. PubMed ID: 7856102
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID.
Yuan H; Yoza BK; Lyles DS
Virology; 1998 Nov; 251(2):383-92. PubMed ID: 9837802
[TBL] [Abstract][Full Text] [Related]
20. Normal replication of vesicular stomatitis virus without C proteins.
Kretzschmar E; Peluso R; Schnell MJ; Whitt MA; Rose JK
Virology; 1996 Feb; 216(2):309-16. PubMed ID: 8607260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
